PreveCeutical Medical Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Stephen Van Deventer
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 6.9yrs |
| CEO ownership | n/a |
| Management average tenure | 6.9yrs |
| Board average tenure | 3.1yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | -CA$518k |
| Jun 30 2023 | n/a | n/a | -CA$1m |
| Mar 31 2023 | n/a | n/a | -CA$1m |
| Dec 31 2022 | n/a | n/a | -CA$1m |
| Sep 30 2022 | n/a | n/a | -CA$2m |
| Jun 30 2022 | n/a | n/a | -CA$1m |
| Mar 31 2022 | n/a | n/a | -CA$2m |
| Dec 31 2021 | CA$123k | CA$120k | -CA$2m |
| Sep 30 2021 | n/a | n/a | -CA$3m |
| Jun 30 2021 | n/a | n/a | -CA$2m |
| Mar 31 2021 | n/a | n/a | -CA$4m |
| Dec 31 2020 | CA$120k | CA$120k | -CA$4m |
| Sep 30 2020 | n/a | n/a | -CA$2m |
| Jun 30 2020 | n/a | n/a | -CA$3m |
| Mar 31 2020 | n/a | n/a | -CA$3m |
| Dec 31 2019 | CA$114k | CA$111k | -CA$4m |
| Sep 30 2019 | n/a | n/a | -CA$9m |
| Jun 30 2019 | n/a | n/a | -CA$11m |
| Mar 31 2019 | n/a | n/a | -CA$12m |
| Dec 31 2018 | CA$173k | CA$170k | -CA$12m |
| Sep 30 2018 | n/a | n/a | -CA$9m |
| Jun 30 2018 | n/a | n/a | -CA$7m |
| Mar 31 2018 | n/a | n/a | -CA$8m |
| Dec 31 2017 | CA$181k | CA$180k | -CA$7m |
Compensation vs Market: Insufficient data to establish whether Stephen's total compensation is reasonable compared to companies of similar size in the Canadian market.
Compensation vs Earnings: Stephen's compensation has increased whilst the company is unprofitable.
CEO
Stephen Van Deventer (54 yo)
6.9yrs
Tenure
CA$123,166
Compensation
Mr. Stephen Van Deventer serves as the Chairman at Preveceutical Medical Inc. and has been its Chief Executive Officer since June 22, 2017, its Director since May 19, 2017 and its Chief Financial Officer s...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 6.9yrs | CA$123.17k | no data | |
| Chief Science Officer | 7.8yrs | CA$75.17k | no data | |
| Head of Artificial Intelligence | 1.1yrs | no data | no data |
6.9yrs
Average Tenure
Experienced Management: PREV's management team is seasoned and experienced (6.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 7yrs | CA$123.17k | no data | |
| Chief Science Officer | 6.6yrs | CA$75.17k | no data | |
| Director | 1.3yrs | no data | no data | |
| Advisor | 3yrs | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Director of PreveCeutical (Australia) Pty Ltd. | 5.6yrs | no data | no data | |
| Advisor & Consultant | 3.2yrs | no data | no data | |
| Director | 1.9yrs | no data | no data | |
| Director | 1.6yrs | no data | no data |
3.1yrs
Average Tenure
67.5yo
Average Age
Experienced Board: PREV's board of directors are considered experienced (3.1 years average tenure).